Syncona Limited (SYNC)

Category Alternative Other
This investment trust can be held in an Investment ISA, SIPP and Investment Account
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.

If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell

95.50p

Buy

96.00p

arrow-up0.80p (+0.84%)

Discount/Premium

-42.92%

Estimated NAV

168.00p

Prices updated at 12 Dec 2025, 16:35 GMT
| Prices minimum 15 mins delay
|
Prices in GBX
Investment objective
The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses and single or multi-asset projects. The Company targets an annualised return per share across its investment portfolio of 15 per cent per annum over the long term.
FTSE All-Share
arrow-down-0.48%
LSE
Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Annual performance (%)

Year
chevron-l-regular
chevron-r-regular
This fundPeer group index
30 Sep 14 - 30 Sep 1510.4922.22
30 Sep 15 - 30 Sep 16-2.211.03
30 Sep 16 - 30 Sep 1752.007.72
30 Sep 17 - 30 Sep 1851.80-0.09
30 Sep 18 - 30 Sep 19-21.4016.12
30 Sep 19 - 30 Sep 2012.6751.10
30 Sep 20 - 30 Sep 21-32.294.72
30 Sep 21 - 30 Sep 22-2.49-11.75
30 Sep 22 - 30 Sep 23-29.20-14.43
30 Sep 23 - 30 Sep 24-2.5823.92
30 Sep 24 - 30 Sep 25-12.87-7.55

Primary benchmark: FTSE 250 TR GBP

Peer group index: Morningstar IT Biotechnology & Healthcare

Trailing returns (%)

Year
chevron-l-regular
chevron-r-regular
This fundPeer group index
1 Day0.840.97
1 Month-4.294.70
3 Months2.0220.73
6 Months9.4732.01
1 Year-6.8916.07
3 Years annualised-18.904.75
5 Years annualised-17.10-0.02

Primary benchmark: FTSE 250 TR GBP

Peer group index: Morningstar IT Biotechnology & Healthcare

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.